Literature DB >> 19356380

Hemodialysis catheter placement via a persistent left superior vena cava.

Y S Jang1, S H Kim, D H Lee, D H Kim, A Y Seo.   

Abstract

Persistent left superior vena cava (PLSVC) is the most common thoracic venous circulation anomaly and discovered incidentally during hemodialysis catheter insertion. PLSVC may have some clinical implications for nephrologists. PLSVC can create difficulties during catheter insertion and cause serious complications; it can be mistaken for placement into other sites and cause inappropriate response such as catheter removal. Nephrologists who place hemodialysis catheters in the left jugular or subclavian vein should be aware of the existence of PLSVC.

Entities:  

Mesh:

Year:  2009        PMID: 19356380     DOI: 10.5414/cnp71448

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  5 in total

1.  Catheterisation of a persistent left superior vena cava.

Authors:  Minakshi Boodhun; Nurashikin Mohammad; Azreen Adnan; Wan Syamimee Wan Ghazali
Journal:  BMJ Case Rep       Date:  2018-07-06

2.  Hemodialysis through persistent left superior vena cava.

Authors:  V B Kute; A V Vanikar; M R Gumber; P R Shah; K R Goplani; H L Trivedi
Journal:  Indian J Crit Care Med       Date:  2011-01

Review 3.  Persistent left superior vena cava: review of the literature, clinical implications, and relevance of alterations in thoracic central venous anatomy as pertaining to the general principles of central venous access device placement and venography in cancer patients.

Authors:  Stephen P Povoski; Hooman Khabiri
Journal:  World J Surg Oncol       Date:  2011-12-28       Impact factor: 2.754

4.  Our encounter with left superior vena cava.

Authors:  Abhijit S Nair; Venugopal Kulkarni; Sunjoy Verma; Ravikiran Mudunuri
Journal:  Indian J Anaesth       Date:  2015-04

5.  Catheterization in a patient with end-stage renal disease through persistent left superior vena cava: a rare case report and literature review.

Authors:  Huisi He; Bingyang Li; Yiyi Ma; Yuqiang Zhang; Chaoyang Ye; Changlin Mei; Shengqiang Yu; Bing Dai; Yawei Liu
Journal:  BMC Nephrol       Date:  2019-06-04       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.